Evaluation of Dabigatran vs Warfarin Before Cardioversion of Atrial Arrhythmias.
作者信息
Tse Mei, Berkson Tara
机构信息
is a clinical pharmacy specialist at the VA Portland Health Care System in Oregon and is an ambulatory care clinical coordinator at CareOregon in Portland.
出版信息
Fed Pract. 2015 Oct;32(10):14-18.
Abstract
Although a quality improvement project supported the use of either dabigatran or warfarin before a planned cardioversion, several factors should be considered when choosing an oral anticoagulant.
摘要
相似文献
1
Evaluation of Dabigatran vs Warfarin Before Cardioversion of Atrial Arrhythmias.
Fed Pract. 2015 Oct;32(10):14-18.
2
Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin-A Nationwide Cohort Study.
PLoS One. 2015 Oct 29;10(10):e0141377. doi: 10.1371/journal.pone.0141377. eCollection 2015.
3
Is one month treatment with dabigatran before cardioversion of atrial fibrillation sufficient to prevent thromboembolism?
Europace. 2015 Oct;17(10):1514-7. doi: 10.1093/europace/euv123. Epub 2015 May 27.
4
Novel Oral Anticoagulants for DC Cardioversion Procedures: Utilization and Clinical Outcomes Compared with Warfarin.
Pacing Clin Electrophysiol. 2015 Jun;38(6):731-7. doi: 10.1111/pace.12618. Epub 2015 Apr 1.
5
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation.
Cardiol Ther. 2016 Dec;5(2):215-221. doi: 10.1007/s40119-016-0067-1. Epub 2016 Jul 25.
6
A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study.
Am Heart J. 2015 May;169(5):597-604.e5. doi: 10.1016/j.ahj.2015.02.009. Epub 2015 Feb 21.
7
The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran.
Pacing Clin Electrophysiol. 2013 Nov;36(11):1328-35. doi: 10.1111/pace.12195. Epub 2013 Aug 16.
8
Novel Oral Anticoagulants in Direct Current Cardioversion for Atrial Fibrillation.
Heart Lung Circ. 2018 Jul;27(7):798-803. doi: 10.1016/j.hlc.2017.06.726. Epub 2017 Jul 17.
9
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
BMJ. 2017 Feb 10;356:j510. doi: 10.1136/bmj.j510.
10
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis.
JACC Cardiovasc Interv. 2019 Dec 9;12(23):2331-2341. doi: 10.1016/j.jcin.2019.08.039.
引用本文的文献
1
A Comparison Between Dabigatran and Warfarin on Time to Elective Cardioversion.
J Atr Fibrillation. 2016 Apr 30;8(6):1355. doi: 10.4022/jafib.1355. eCollection 2016 Apr-May.
本文引用的文献
1
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.
Circulation. 2014 Dec 2;130(23):2071-104. doi: 10.1161/CIR.0000000000000040. Epub 2014 Mar 28.
2
Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation).
J Am Coll Cardiol. 2014 Mar 25;63(11):1082-7. doi: 10.1016/j.jacc.2013.09.062. Epub 2013 Nov 6.
3
Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial.
J Am Coll Cardiol. 2013 May 14;61(19):1998-2006. doi: 10.1016/j.jacc.2013.02.025. Epub 2013 Mar 14.
4
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Chest. 2012 Feb;141(2 Suppl):e531S-e575S. doi: 10.1378/chest.11-2304.
5
Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
Circulation. 2011 Jan 18;123(2):131-6. doi: 10.1161/CIRCULATIONAHA.110.977546. Epub 2011 Jan 3.
6
Dabigatran versus warfarin in patients with atrial fibrillation.
N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Epub 2009 Aug 30.
7
Timing of thromboembolic events after electrical cardioversion of atrial fibrillation or flutter: a retrospective analysis.
Am J Cardiol. 1998 Dec 15;82(12):1545-7, A8. doi: 10.1016/s0002-9149(98)00704-8.
8
9
Patient characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with oral sotalol.
Am Heart J. 1997 Sep;134(3):419-25. doi: 10.1016/s0002-8703(97)70076-0.
10
Cardioversion of atrial fibrillation: consideration of embolization, anticoagulation, prophylactic pacemaker, and long-term success.
Am Heart J. 1982 Sep;104(3):617-21. doi: 10.1016/0002-8703(82)90236-8.
Zotero 插件